MedTech Acquisition Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MTAC research report →
Company
MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.
- CEO
- Christopher C. Dewey
- IPO
- 2021
- HQ
- Greenwich, CT, US
Price Chart
Valuation
- Market Cap
- $83.86M
- P/E
- -6.11
- P/S
- 2.74
- P/B
- 13.04
- EV/EBITDA
- -3.12
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 85.07%
- Op Margin
- -62.45%
- Net Margin
- -60.85%
- ROE
- 162.57%
- ROIC
- -47.18%
Growth & Income
- Revenue
- $45.15M · 53.41%
- Net Income
- $-69,690,000 · -109.70%
- EPS
- $-1.84 · -73.58%
- Op Income
- $-26,946,000
- FCF YoY
- 53.65%
Performance & Tape
- 52W High
- $12.83
- 52W Low
- $8.43
- 50D MA
- $10.41
- 200D MA
- $10.22
- Beta
- -0.02
- Avg Volume
- 13.97K
Get TickerSpark's AI analysis on MTAC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 30, 23 | Devlin Jodi | other | 195,000 |
| Aug 28, 23 | Devlin Jodi | other | 0 |
| Aug 14, 23 | Szela Mary T | other | 172,500 |
| Aug 10, 23 | Szela Mary T | other | 0 |
| Aug 10, 23 | Szela Mary T | other | 55,616 |
| Aug 10, 23 | Szela Mary T | other | 101,345 |
| Aug 10, 23 | Szela Mary T | other | 58,409 |
| Aug 10, 23 | Szela Mary T | other | 177,973 |
| Aug 11, 23 | Stevens Jennifer | other | 40,000 |
| Aug 10, 23 | Stevens Jennifer | other | 0 |
Our MTAC Coverage
We haven't published any research on MTAC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MTAC Report →